Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer

NCT05643677 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Fruquintinib
DRUG: Irinotecan

Sponsor

Fujian Medical University